Search results
Found 123 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology
General Innovation Research
6 April 2022
The contribution of individual features on clinical imaging scans to the performance of the LCP-CNN cancer risk prediction model developed in Oxford was investigated.
Oxford University retains top spot for spinout generation in the UK
General Innovation
4 April 2022
Oxford University has been ranked first in the UK for turning academic research into spinout companies, according to a new report published today by data analyst firm Beauhurst.
The glass half full man: Professor Chas Bountra and Oxford's innovative future
General Innovation
1 April 2022
Forget the TV clichés about Oxford – all punting and pass the port. The 925-year-old university is full of the most amazing people who are helping and benefiting the world, well beyond the quads and spires, says Professor Chas Bountra, the university’s Pro-Vice-Chancellor for Innovation. After the events of the last two years - and the COVID-19 vaccine [2.5 billion doses delivered and counting] - this most enthusiastic champion of Oxford maintains there can be no doubt, innovation is part and parcel of the historic university’s future. Who knows what is coming next, he says, expectantly.
Exscientia and University of Oxford launch “Xcellomics” program to expedite early-stage academic research and translate novel biology into future drug discovery
General Innovation Research
10 March 2022
Exscientia and the University of Oxford's Target Discovery Institute (TDI) today announced the formation of Xcellomics – a program designed to source cellular functional assays from the global academic community to develop novel screens and identify targets and therapeutic candidates for unmet medical needs.
Professor Collins awarded Sir Jules Thorn Translational Biomedical Research Award 2021
Awards and Appointments General Innovation Research
2 March 2022
Professor Sally Collins has been awarded the prestigious and highly competitive Sir Jules Thorn Translational Biomedical Research Award 2021 for further translational development of the OxNNet Toolkit.
Sir Jon Symonds joins Pharmacology as a Visiting Fellow
Awards and Appointments General Innovation
14 February 2022
The Department of Pharmacology is delighted to announce the appointment of Sir Jonathan Symonds CBE, Chair of the Board of GlaxoSmithKline, as a Visiting Fellow. Jon has been Chairman of the Board at GSK since September 2019.
Medical Sciences welcomes Steve Bates as Royal Society Entrepreneur in Residence
Awards and Appointments General Innovation
3 February 2022
The Medical Sciences Division welcomes Steve Bates, CEO of the UK Bioindustry Association, as a Royal Society Entrepreneur in Residence. Steve Bates will be working very closely with our Translational Research Office and key teams across the University of Oxford's innovation ecosystem.
New Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease
General Innovation
3 December 2021
GlaxoSmithKline plc and the University of Oxford today announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine.
Jenner Institute named Covid Innovation Heroes
Awards and Appointments General Innovation
26 November 2021
The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award 2021.
Oxford joins consortium to advance quantum drug discovery with £6.8M grant from Innovate UK
General Innovation Research
5 November 2021
Oxford University today joins a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug development for Merck KGaA.
AIMday in Women's Health - registration for academics now open
Events Innovation
14 October 2021
Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.
Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme
Awards and Appointments General Innovation
11 October 2021
The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.
Anti-cancer drug derived from fungus shows promise in clinical trials
Clinical Trials General Innovation Research
7 October 2021
A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.
Oxford BioEscalator celebrates three years of innovation
General Innovation
13 September 2021
The BioEscalator concept was born out of a shared need by academic researchers and their bioscience company collaborators for start-up incubator space close to academic labs. The vision was to develop a leading international centre for innovative bioscience with the potential to make a significant impact on healthcare. The incubator provides spin-outs and start-ups with laboratory and business support, enabling them to grow into leading bioscience ventures.
Immunology and AI drug discovery partnership agreed with Sensyne Health
General Innovation Research
25 August 2021
The University has signed an agreement with Sensyne Health to conduct a multi-omics drug discovery research project in asthma. The project will be led by Dr Timothy Hinks and his team at the Nuffield Department of Medicine’s Respiratory Medicine Unit.
Oxford overseas research facility expands to include diagnostics and genetics testing centre
General Innovation
12 July 2021
The Oxford-Suzhou Centre for Advanced Research, known as OSCAR, has marked another significant milestone with the launch of OSCAR-Prenetics Innovation and Technology Centre for Advanced Molecular Diagnostics (the OSCAR-Prenetics ITC).
Oxford joins forces with 11 universities to launch social impact investment fund
General Innovation
23 June 2021
The University of Oxford has joined forces with 11 leading universities to create Impact 12, an impact investment fund to support mission-led university ventures.
AIMday in Experimental Medicine in Psychiatry - registration for academics now open
Events Innovation
1 June 2021
Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Experimental Medicine in Psychiatry.
Innovation award for Professor Anindita Roy to develop new treatments for childhood cancer
Awards and Appointments General Innovation Research
18 March 2021
Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.
Oxford vaccine creator Professor Sarah Gilbert awarded RSA Albert Medal
Awards and Appointments Coronavirus COVID-19 General Innovation Research
5 March 2021
Professor Sarah Gilbert has been awarded the Royal Society for Arts, Manufactures and Commerce’ (RSA) Albert Medal for her work on the Oxford vaccine.